During the past decade, Ade Meidian Ambari conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ade Meidian Ambari" are "ACE Inhibitor" (1 trials), "Angiogenesis" (1 trials), "Cardiac Rehabilitation" (1 trials), "Fibrosis; Heart" (1 trials) and "Mitral Stenosis" (1 trials). Many other conditions were trialed in "Ade Meidian Ambari" in a lesser frequency.

Most popular intervention types in "Ade Meidian Ambari" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "External Counter Pulsation (ECP) therapy" (1 trials), "Placebos" (1 trials) and "Ramipril 5Mg Oral Capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ade Meidian Ambari" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ade Meidian Ambari". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ade Meidian Ambari, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ade Meidian Ambari, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".